ALPINE IMMUNE SCIENCES, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q4 2023.
  • Alpine Immune Sciences, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $103K.
  • Alpine Immune Sciences, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $103K.
  • Alpine Immune Sciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $103K, a 95.6% decline from 2022.
  • Alpine Immune Sciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $2.33M.
  • Alpine Immune Sciences, Inc. annual Income Tax Expense (Benefit) for 2021 was -$87K, a 1350% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $103K $103K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $0 -$1.78M -100% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $0 -$4K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q3 2022 $1.48M $0 -$80K -100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.56M $1.78M +$1.65M +1257% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$83K $4K +$4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$87K -$298K Oct 1, 2021 Dec 31, 2021 10-K 2024-03-20
Q3 2021 $80K +$80K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $131K +$137K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$6K -$6K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q4 2019 $0 $0 +$61K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 -$61K $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$61K $0 +$253K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$314K $0 +$52K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$366K -$61K +$143K +70.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 -$509K $0 -$4K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$505K -$253K -$253K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$252K -$52K -$52K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$200K -$204K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 $4K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.